The new BD COR MX instrument, which received 510(k) clearance from the US Food and Drug Administration (FDA), is used as the new analytic instrument option for the BD COR System

BD_COR_tm__MX_PX

The BD COR MX/PX System. (Credit: BD)

Medical technology company BD (Becton, Dickinson and Company) has introduced a new fully automated, high-throughput molecular diagnostics platform, BD COR MX System.

The new BD COR MX instrument, which received 510(k) clearance from the US Food and Drug Administration (FDA), is used as the new analytic instrument option for the BD COR System.

According to the company, the first test available on the new system is BD CTGCTV2 molecular assay, which is a single test.

It is capable of detecting the three most common non-viral sexually transmitted diseases (STIs): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

The BD COR MX/PX System combines and automates the overall molecular laboratory workflow, from sample processing to diagnostic test results for high-throughput labs.

It also eliminates the need to sort specimens, allowing the lab technicians to utilise the time saved for other important lab processes.

The system allows the loading of 1,700 specimens with a capacity for reagents and samples allowing more than seven hours of the uninterrupted system processing.

BD’s system is capable of sending up to 1,000 sample results in 24 hours, removing the need for multiple manual interactions per shift.

It also has dual DNA targets for CT and GC detection in the same sample and test, potentially reducing false positives, the firms said.

BD integrated diagnostic solutions president Brooke Story said: “Even before COVID-19, clinicians and laboratory technicians were faced with increasing workloads and patient needs, and now those challenges have been amplified significantly by the ongoing staffing shortages and further increased workloads caused by the pandemic.

“By automating labour-intensive and mundane error-prone processes, the BD COR MX/PX System allows lab technicians and clinicians to focus on higher-value work.”

The sample collection method for the system includes self-collection (in a clinical setting), vaginal/endocervical swab, urine (both male and female), and liquid-based cytology.

Last month, the company launched a new AI-based range of reagents, BD Horizon RealYellow 586 Reagents for flow cytometry.